2023
Tobacco use and cancer‐related symptom burden: Analysis of the US Population Assessment of Tobacco and Health Study
Price S, Palmer A, Fucito L, Graboyes E, Baker N, Rojewski A, Toll B. Tobacco use and cancer‐related symptom burden: Analysis of the US Population Assessment of Tobacco and Health Study. Cancer 2023, 129: 2385-2394. PMID: 37211959, PMCID: PMC10593116, DOI: 10.1002/cncr.34746.Peer-Reviewed Original ResearchConceptsSymptom burdenCurrent smokingCigarette smokingQuit attemptsTobacco useGreater fatiguePast-year quit attemptsCancer symptom burdenUS Population AssessmentCurrent cigarette smokingGreater symptom burdenTobacco treatment interventionsAdult cancer survivorsQuality of lifeSmoking quit attemptEmotional problemsRace/ethnicityCancer survivorsTobacco cessationHealth StudySmokingTreatment interventionsUS FoodMultivariate analysisSurvivors' interest
2022
Urgent Need for Novel Investigations of Treatments to Quit E-cigarettes: Findings from a Systematic Review
Palmer AM, Price SN, Foster MG, Sanford BT, Fucito LM, Toll BA. Urgent Need for Novel Investigations of Treatments to Quit E-cigarettes: Findings from a Systematic Review. Cancer Prevention Research 2022, 15: 569-580. PMID: 35816038, PMCID: PMC9444997, DOI: 10.1158/1940-6207.capr-22-0172.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultCigarette SmokingElectronic Nicotine Delivery SystemsHumansSmoking CessationTobacco ProductsVapingConceptsE-cigarette cessationE-cigarettesSystematic reviewE-cigarette useSymptoms of dependenceCohort studyCigarette smokingPsychologic factorsQuit attemptsHealth concernCessationCold turkeySmokingLack of satisfactionHigher intentFuture studiesAdultsInterventionAdult samplesUrgent needLack of informationReviewSymptomsAbstinenceIndividualsCigarette Smoking in Response to COVID-19: Examining Co-Morbid Medical Conditions and Risk Perceptions
Fucito LM, Bold KW, Cannon S, Serrantino A, Marrero R, O’Malley S. Cigarette Smoking in Response to COVID-19: Examining Co-Morbid Medical Conditions and Risk Perceptions. International Journal Of Environmental Research And Public Health 2022, 19: 8239. PMID: 35886090, PMCID: PMC9317071, DOI: 10.3390/ijerph19148239.Peer-Reviewed Original ResearchMeSH KeywordsAdultCigarette SmokingCOVID-19Electronic Nicotine Delivery SystemsHumansPandemicsTobaccoTobacco Use CessationConceptsChronic medical conditionsMedical conditionsCigarette smokingCOVID-19 risk perceptionCOVID-19 riskGreater oddsSmoking changesHigher COVID-19 risk perceptionsCo-morbid medical conditionsCOVID-19Tobacco cessation treatmentCoronavirus disease 2019 (COVID-19) pandemicDisease 2019 pandemicPublic health threatCessation treatmentMedical historyWhite raceSmokingSmoking behaviorSample of adultsOngoing COVID-19Younger ageLogistical regressionHealth threatPreventive healthcare
2021
Cigarette Smoking and Heavy Alcohol Drinking: The Challenges and Opportunities for Combination Treatments
King A, Fucito L. Cigarette Smoking and Heavy Alcohol Drinking: The Challenges and Opportunities for Combination Treatments. American Journal Of Psychiatry 2021, 178: 783-785. PMID: 34516230, DOI: 10.1176/appi.ajp.2021.21070692.Peer-Reviewed Original ResearchThe effect of varenicline on smoking and drinking outcomes among Black and White adults with alcohol use disorder and co-occurring cigarette smoking: A secondary analysis of two clinical trials
Haeny AM, Gueorguieva R, Montgomery L, Bold KW, Fucito LM, Wu R, Muvvala SB, Zweben A, O'Malley SS. The effect of varenicline on smoking and drinking outcomes among Black and White adults with alcohol use disorder and co-occurring cigarette smoking: A secondary analysis of two clinical trials. Addictive Behaviors 2021, 122: 106970. PMID: 34216871, PMCID: PMC9426655, DOI: 10.1016/j.addbeh.2021.106970.Peer-Reviewed Original ResearchMeSH KeywordsAdultAlcoholismCigarette SmokingDouble-Blind MethodFemaleHumansMaleSmokingSmoking CessationTreatment OutcomeVareniclineConceptsEffects of vareniclineAlcohol use disorderCigarette smokingClinical trialsUse disordersWhite adultsEfficacy of vareniclineNumber of drinksVareniclineSmokingPrimary analysisAlcohol treatmentSecondary analysisAlcohol useTrialsBlack participantsDrinking outcomesLinear mixed modelsAdultsWhite peopleWhite participantsMixed modelingCigarettesDisordersTreatmentClearing the Haze: What Do We Still Need to Learn about Electronic Nicotine Delivery Systems?
Fucito LM, Malinosky H, Baldassarri SR, Herbst RS. Clearing the Haze: What Do We Still Need to Learn about Electronic Nicotine Delivery Systems? Cancer Prevention Research 2021, 14: 5-10. PMID: 33148678, PMCID: PMC8324047, DOI: 10.1158/1940-6207.capr-20-0394.Peer-Reviewed Original Research
2019
Longitudinal Findings from a Randomized Clinical Trial of Varenicline for Alcohol Use Disorder with Comorbid Cigarette Smoking
Bold KW, Zweben A, Fucito LM, Piepmeier ME, Muvvala S, Wu R, Gueorguieva R, O'Malley SS. Longitudinal Findings from a Randomized Clinical Trial of Varenicline for Alcohol Use Disorder with Comorbid Cigarette Smoking. Alcohol Clinical And Experimental Research 2019, 43: 937-944. PMID: 30817018, PMCID: PMC7039307, DOI: 10.1111/acer.13994.Peer-Reviewed Original ResearchConceptsEnd of treatmentAlcohol use disorderHeavy drinking daysMedical managementCigarette smokingComorbid cigarette smokingUse disordersDrinking daysCo-occurring alcohol use disorderHigh ratePlacebo-controlled trialBetter clinical outcomesAssessment of alcoholPercent of participantsVarenicline treatmentClinical outcomesSmoking abstinenceParallel groupClinical trialsTimeline FollowVareniclineSmoking behaviorAlcohol treatmentPosttreatment outcomesMultisite trial